Progress in the Treatment of Heamatologic and Internal Diseases

Providing the basis for understanding the evolution of personalized medicine as an innovative approach to the treatment of internal diseases, with particular attention to hematological diseases. Particular attention will be given to: 1) understanding the evolution of treatments available for hemophilia, both from a biological and clinical point of view, 2) understanding of progress in the assessment of musculoskeletal complications in congenital hemorrhagic diseases, 3) planning laboratory work with cell and animal models to answer questions of clinical interest in the field of portal hypertension, 4) To update knowledge of the current approach to the diseases characterized by increased microvascular permeability.